Boditech Diagnostic Solutions: The Leaders in Point of Care Testing

At Caribbean Medical Supplies (CMSI), we believe in equipping healthcare professionals with cutting-edge tools that improve diagnostic accuracy and patient care. As the sole authorized distributor for Boditech in Guyana, Trinidad, and Suriname – now expanding service to Antigua and Barbuda, Barbados, Grenada, and St. Lucia – we’re proud to bring the latest in Point of Care Testing (POCT) technology to the Caribbean.

 

Explore our Boditech Diagnostic Product Line below:

🔬 Immunoassay Analyzers

AFIAS 1

This is a single-channel lateral flow immunoassay platform with a disposable cartridge containing all necessary test reagents.

AFIAS 3

AFIAS-3 is a compact, three-channel platform for simultaneous testing, ideal for small labs, hospitals, and clinics.

AFIAS 6

AFIAS-6 is a unique integrated system with 6 parallel tests, fast results, and high sensitivity, matching commercial lab systems.

AFIAS 10

AFIAS-10 is an integrated system that performs 10 parallel tests, providing quick, reliable results with automatic blood tube sampling.

 

⚛️ iChroma Series

iChroma II

ichroma™ II is a compact, easy-to-use analyzer for detecting biomarkers in cardiac, cancer, hormone, infectious, autoimmune, and metabolic diseases.

iChroma M2

Ichroma™ M2 is a portable, hand-held immunoassay reader compatible with Boditech Med’s cartridges, optimized for diagnosing respiratory infections like COVID-19, influenza, and RSV.

iChroma M3

Ichroma™ M3 is a portable, hand-held immunoassay reader for CRP tests, compatible with Boditech Med’s cartridges and powered by external batteries.

🩸 Hemoglobin Analyzer

Hemochroma PLUS

Hemochroma PLUS is a handheld device for anemia tests, using a disposable cuvette for fingertip blood samples or a pipette for tube blood. Results take 3-5 seconds and can be transmitted to a host computer.

📥 Download the brochure here: Boditech – Trifold Brochure

🏥 Why Choose CMSI & Boditech

With over 30 years of combined industry experience, Caribbean Medical Supplies continues to lead the charge in supplying the region with dependable, high-quality medical technology.

Our partnership with Boditech reflects our commitment to:

  • Offering affordable and innovative diagnostic solutions

  • Building lasting partnerships across the region

  • Ensuring healthcare professionals are equipped with trusted tools that support better patient outcom

🩺 Want to learn more or place an order?
📞 Call us at 592-504-6299 / 698-7987 / 680-3828
📧 Email: [email protected]
🌍 Visit: www.cmsigy.com

Boditech Interleukin-6

Interleukin-6

The earliest alarming for sepsis

Every minute and every second, the medical team had always encountered challenges. The clinicians kept thinking about how to detect a baby’s condition earlier and how to reduce antibiotics administration. Interleukin-6 acts as a pro-inflammation cytokine and a key mediator of inflammation. During the acute phase of infection, B and T lymphocytes are stimulated to produce the Interleukin-6 cytokine, which in turn induces hepatocyte production of acute-phase reactants such as CRP.

With these characteristics, the Interleukin-6 could help to detect EOS(Early Onset Sepsis) earlier and can work as a complementary function with existing tests such as CRP(C-Reactive Protein) and PCT(Procalcitonin). Boditech Med has launched the AFIAS Interleukin-6 in September 2020, and it has been landed successfully. It is expected that the AFIAS Interleukin-6 test aid to detect inflammation in the early stage and will contribute to improving the newborn’s health.

 

Interleukin-6, an essential test for NICU and children’s hospital

1. Early Onset Sepsis occurs within 72 hours of life

Neonatal sepsis is a major contributor to morbidity and mortality in neonates, especially in those born preterm. The Global Burden of Disease (GBD) estimated 1.3 million annual incident cases of neonatal sepsis and other infections 2,874 sepsis cases per 100,000 live births and a mortality of 17.6%.

2. Exposure to inappropriate and/or excessive antibiotic use

Antibiotics are the most commonly prescribed class of medications in the NICU. The probability of EOS combined with the clinical instability characteristic of premature newborns leads to high rates of empirical antibiotic treatment. previous studies demonstrate that neonatal clinicians administer antibiotics from birth in 79% to 98%.

3. C-tip is the ideal method for infants’ or children’s sample collection

An infant’s blood collection cannot exceed 1% of body blood, usually premature baby is under 2 kg therefore, 1 ml for once is maximum. The research shows, that 51.7% of hospitals in Korea collect 0.5 ml, and 24.1% collect 1 ml from an infant’s heel for a blood culture test. It is already in the dangerous range for infants.

NICU clinicians need the method to improve diagnostic capabilities, which can provide reliable results, early and rapid, simple and safely in the patient’s bedside or in the ICU.

AFIAS parameters

ichroma parameters

Search

+
Select your currency